tiprankstipranks
Trending News
More News >
AEON Biopharma (AEON)
:AEON
US Market

AEON Biopharma (AEON) Financial Statements

Compare
221 Followers

AEON Biopharma Financial Overview

AEON Biopharma's market cap is currently $13.80M. The company's EPS TTM is $-0.39; its P/E ratio is 0.23; AEON Biopharma is scheduled to report earnings on November 14, 2025, and the estimated EPS forecast is $-0.13. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 2.52M
Gross Profit$ 0.00$ 0.00$ 0.00$ 0.00$ 2.52M
Operating Income$ 72.98M$ -348.09M$ -48.43M$ -65.85M$ -16.39M
EBITDA$ -27.73M$ -52.74M$ -48.36M$ -36.88M$ -15.51M
Net Income$ 42.01M$ -384.63M$ -52.56M$ -55.64M$ -32.91M
Balance Sheet
Cash & Short-Term Investments$ 13.00K$ 5.16M$ 9.75M$ 5.13M$ 20.17M
Total Assets$ 3.14M$ 6.84M$ 10.78M$ 6.44M$ 21.21M
Total Debt$ 12.96M$ 278.00K$ 131.53M$ 86.89M$ 72.16M
Net Debt$ 12.94M$ -4.88M$ 121.79M$ 81.76M$ 51.99M
Total Liabilities$ 31.71M$ 159.89M$ 281.19M$ 230.26M$ 224.45M
Stockholders' Equity$ -28.57M$ -153.04M$ -287.50M$ -234.94M$ -208.27M
Cash Flow
Free Cash Flow$ -20.29M$ -47.83M$ -35.89M$ -28.60M$ -9.46M
Operating Cash Flow$ -20.29M$ -47.83M$ -35.58M$ -28.43M$ -9.46M
Investing Cash Flow$ 0.00$ 0.00$ -306.00K$ -170.00K$ -1.26M
Financing Cash Flow$ 15.15M$ 14.00M$ 40.51M$ 13.56M$ 24.57M
Currency in USD

AEON Biopharma Earnings and Revenue History

AEON Biopharma Debt to Assets

AEON Biopharma Cash Flow

AEON Biopharma Forecast EPS vs Actual EPS